182 related articles for article (PubMed ID: 11274927)
1. VAP-1: an adhesin and an enzyme.
Salmi M; Jalkanen S
Trends Immunol; 2001 Apr; 22(4):211-6. PubMed ID: 11274927
[TBL] [Abstract][Full Text] [Related]
2. A cell surface amine oxidase directly controls lymphocyte migration.
Salmi M; Yegutkin GG; Lehvonen R; Koskinen K; Salminen T; Jalkanen S
Immunity; 2001 Mar; 14(3):265-76. PubMed ID: 11290336
[TBL] [Abstract][Full Text] [Related]
3. Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate.
Kivi E; Elima K; Aalto K; Nymalm Y; Auvinen K; Koivunen E; Otto DM; Crocker PR; Salminen TA; Salmi M; Jalkanen S
Blood; 2009 Dec; 114(26):5385-92. PubMed ID: 19861682
[TBL] [Abstract][Full Text] [Related]
4. In vivo detection of vascular adhesion protein-1 in experimental inflammation.
Jaakkola K; Nikula T; Holopainen R; Vähäsilta T; Matikainen MT; Laukkanen ML; Huupponen R; Halkola L; Nieminen L; Hiltunen J; Parviainen S; Clark MR; Knuuti J; Savunen T; Kääpä P; Voipio-Pulkki LM; Jalkanen S
Am J Pathol; 2000 Aug; 157(2):463-71. PubMed ID: 10934150
[TBL] [Abstract][Full Text] [Related]
5. Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation.
Salmi M; Jalkanen S
Antioxid Redox Signal; 2019 Jan; 30(3):314-332. PubMed ID: 29065711
[No Abstract] [Full Text] [Related]
6. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress.
Yegutkin GG; Salminen T; Koskinen K; Kurtis C; McPherson MJ; Jalkanen S; Salmi M
Eur J Immunol; 2004 Aug; 34(8):2276-85. PubMed ID: 15259025
[TBL] [Abstract][Full Text] [Related]
7. Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo.
Tohka S; Laukkanen M; Jalkanen S; Salmi M
FASEB J; 2001 Feb; 15(2):373-82. PubMed ID: 11156953
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1).
Koskinen K; Vainio PJ; Smith DJ; Pihlavisto M; Ylä-Herttuala S; Jalkanen S; Salmi M
Blood; 2004 May; 103(9):3388-95. PubMed ID: 14726375
[TBL] [Abstract][Full Text] [Related]
9. Endothelial amine oxidase AOC3 transiently contributes to adaptive immune responses in the airways.
Dunkel J; Aguilar-Pimentel JA; Ollert M; Fuchs H; Gailus-Durner V; de Angelis MH; Jalkanen S; Salmi M; Veres TZ
Eur J Immunol; 2014 Nov; 44(11):3232-9. PubMed ID: 25116373
[TBL] [Abstract][Full Text] [Related]
10. Functional modulation of vascular adhesion protein-1 by a novel splice variant.
Kaitaniemi S; Grön K; Elovaara H; Salmi M; Jalkanen S; Elima K
PLoS One; 2013; 8(1):e54151. PubMed ID: 23349812
[TBL] [Abstract][Full Text] [Related]
11. Induction and function of vascular adhesion protein-1 at sites of inflammation.
Salmi M; Kalimo K; Jalkanen S
J Exp Med; 1993 Dec; 178(6):2255-60. PubMed ID: 8245796
[TBL] [Abstract][Full Text] [Related]
12. Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear.
Salmi M; Tohka S; Jalkanen S
Circ Res; 2000 Jun; 86(12):1245-51. PubMed ID: 10864915
[TBL] [Abstract][Full Text] [Related]
13. Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+ myeloid cells into tumors.
Marttila-Ichihara F; Auvinen K; Elima K; Jalkanen S; Salmi M
Cancer Res; 2009 Oct; 69(19):7875-83. PubMed ID: 19789345
[TBL] [Abstract][Full Text] [Related]
14. VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation.
Jalkanen S; Salmi M
Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):18-26. PubMed ID: 17962625
[TBL] [Abstract][Full Text] [Related]
15. Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo.
Stolen CM; Marttila-Ichihara F; Koskinen K; Yegutkin GG; Turja R; Bono P; Skurnik M; Hänninen A; Jalkanen S; Salmi M
Immunity; 2005 Jan; 22(1):105-15. PubMed ID: 15664163
[TBL] [Abstract][Full Text] [Related]
16. [Vascular adhesion protein-1 (VAP-1) in inflammatory process].
Pietruczuk M; Pietruczuk A; Zajkowska J; Pancewicz S; Hermanowska-Szpakowicz T
Przegl Lek; 2006; 63(4):220-2. PubMed ID: 17083159
[TBL] [Abstract][Full Text] [Related]
17. Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans.
Salmi M; Jalkanen S
Blood; 2006 Sep; 108(5):1555-61. PubMed ID: 16556889
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.
Sun P; Hernandez-Guillamón M; Campos-Martorell M; Simats A; Montaner J; Unzeta M; Solé M
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):542-553. PubMed ID: 29175057
[TBL] [Abstract][Full Text] [Related]
19. Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans.
Jaakkola K; Jalkanen S; Kaunismäki K; Vänttinen E; Saukko P; Alanen K; Kallajoki M; Voipio-Pulkki LM; Salmi M
J Am Coll Cardiol; 2000 Jul; 36(1):122-9. PubMed ID: 10898423
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice.
Marttila-Ichihara F; Castermans K; Auvinen K; Oude Egbrink MG; Jalkanen S; Griffioen AW; Salmi M
J Immunol; 2010 Mar; 184(6):3164-73. PubMed ID: 20154208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
